| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATXN3L BPTF SP1 SP3 SP4 ARGFX ZFHX4 FOXP2 CCAR1 POU2F1 FOXP1 ZNF853 RFXAP CREBBP PROX1 | 1.32e-04 | 1459 | 70 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.32e-04 | 140 | 70 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.94e-04 | 37 | 70 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.74e-04 | 303 | 70 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.87e-04 | 118 | 70 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SP1 SP3 SP4 KMT2D ARGFX ZFHX4 FOXP2 YLPM1 POU2F1 FOXP1 ZNF853 RFXAP PROX1 | 1.12e-03 | 1412 | 70 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | BPTF SP1 SP3 SP4 ARGFX ZFHX4 FOXP2 CCAR1 POU2F1 FOXP1 ZNF853 PROX1 | 1.19e-03 | 1244 | 70 | 12 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription factor binding | 1.22e-03 | 753 | 70 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.35e-03 | 614 | 70 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | BPTF SP1 SP3 SP4 ARGFX ZFHX4 FOXP2 CCAR1 POU2F1 FOXP1 ZNF853 PROX1 | 1.44e-03 | 1271 | 70 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.79e-03 | 18 | 70 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.91e-03 | 70 | 70 | 3 | GO:0003777 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 1.38e-05 | 14 | 71 | 3 | GO:0002318 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 3.50e-05 | 3 | 71 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | olfactory placode morphogenesis | 1.16e-04 | 5 | 71 | 2 | GO:0071699 | |
| GeneOntologyBiologicalProcess | olfactory placode development | 1.16e-04 | 5 | 71 | 2 | GO:0071698 | |
| GeneOntologyBiologicalProcess | olfactory placode formation | 1.16e-04 | 5 | 71 | 2 | GO:0030910 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 1.34e-04 | 29 | 71 | 3 | GO:0048745 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 1.80e-04 | 32 | 71 | 3 | GO:0048596 | |
| HumanPheno | Prominent fingertip pads | 2.74e-06 | 46 | 26 | 5 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 3.40e-06 | 48 | 26 | 5 | HP:0011298 | |
| Domain | Sp1_fam | 6.47e-06 | 10 | 72 | 3 | IPR030450 | |
| Domain | PHD | 1.03e-05 | 75 | 72 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 1.34e-05 | 79 | 72 | 5 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 2.19e-05 | 147 | 72 | 6 | IPR011011 | |
| Domain | PHD | 2.39e-05 | 89 | 72 | 5 | SM00249 | |
| Domain | Znf_PHD | 2.66e-05 | 91 | 72 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.27e-05 | 95 | 72 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 3.44e-05 | 96 | 72 | 5 | PS01359 | |
| Domain | GYF | 4.39e-05 | 3 | 72 | 2 | SM00444 | |
| Domain | GYF | 4.39e-05 | 3 | 72 | 2 | PS50829 | |
| Domain | GYF | 4.39e-05 | 3 | 72 | 2 | PF02213 | |
| Domain | FAM117 | 4.39e-05 | 3 | 72 | 2 | PF15388 | |
| Domain | - | 4.39e-05 | 3 | 72 | 2 | 3.30.1490.40 | |
| Domain | Glcci1/FAM117 | 4.39e-05 | 3 | 72 | 2 | IPR026642 | |
| Domain | FOXP-CC | 8.75e-05 | 4 | 72 | 2 | PF16159 | |
| Domain | FOXP-CC | 8.75e-05 | 4 | 72 | 2 | IPR032354 | |
| Domain | GYF | 8.75e-05 | 4 | 72 | 2 | IPR003169 | |
| Domain | DDT | 8.75e-05 | 4 | 72 | 2 | PF02791 | |
| Domain | Bromodomain_CS | 1.34e-04 | 26 | 72 | 3 | IPR018359 | |
| Domain | DDT | 1.45e-04 | 5 | 72 | 2 | SM00571 | |
| Domain | WSD | 1.45e-04 | 5 | 72 | 2 | PF15613 | |
| Domain | DDT_dom | 1.45e-04 | 5 | 72 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 1.45e-04 | 5 | 72 | 2 | IPR028941 | |
| Domain | DDT | 2.18e-04 | 6 | 72 | 2 | PS50827 | |
| Domain | BROMODOMAIN_1 | 3.88e-04 | 37 | 72 | 3 | PS00633 | |
| Domain | Bromodomain | 4.21e-04 | 38 | 72 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.27e-04 | 41 | 72 | 3 | PS50014 | |
| Domain | BROMO | 5.66e-04 | 42 | 72 | 3 | SM00297 | |
| Domain | Bromodomain | 5.66e-04 | 42 | 72 | 3 | IPR001487 | |
| Domain | - | 5.66e-04 | 42 | 72 | 3 | 1.20.920.10 | |
| Domain | NCD3G | 1.11e-03 | 13 | 72 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.11e-03 | 13 | 72 | 2 | IPR011500 | |
| Domain | Dynein_HC_stalk | 1.29e-03 | 14 | 72 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.29e-03 | 14 | 72 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.29e-03 | 14 | 72 | 2 | PF08393 | |
| Domain | MT | 1.29e-03 | 14 | 72 | 2 | PF12777 | |
| Domain | GPCR_3_CS | 1.29e-03 | 14 | 72 | 2 | IPR017979 | |
| Domain | DHC_fam | 1.49e-03 | 15 | 72 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.49e-03 | 15 | 72 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.49e-03 | 15 | 72 | 2 | PF03028 | |
| Domain | RmlC_Cupin | 1.70e-03 | 16 | 72 | 2 | IPR011051 | |
| Domain | Zinc_finger_PHD-type_CS | 2.02e-03 | 65 | 72 | 3 | IPR019786 | |
| Domain | GPCR_3 | 2.94e-03 | 21 | 72 | 2 | IPR000337 | |
| Domain | - | 2.94e-03 | 21 | 72 | 2 | 1.10.720.30 | |
| Domain | EPHD | 3.22e-03 | 22 | 72 | 2 | PS51805 | |
| Domain | 7tm_3 | 3.22e-03 | 22 | 72 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.22e-03 | 22 | 72 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.22e-03 | 22 | 72 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.22e-03 | 22 | 72 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.22e-03 | 22 | 72 | 2 | PS50259 | |
| Domain | GPCR_3_C | 3.22e-03 | 22 | 72 | 2 | IPR017978 | |
| Domain | SAP | 3.22e-03 | 22 | 72 | 2 | PF02037 | |
| Domain | SAP | 3.52e-03 | 23 | 72 | 2 | SM00513 | |
| Domain | SAP | 4.15e-03 | 25 | 72 | 2 | PS50800 | |
| Domain | SAP_dom | 4.15e-03 | 25 | 72 | 2 | IPR003034 | |
| Domain | ZnF_U1 | 5.56e-03 | 29 | 72 | 2 | SM00451 | |
| Domain | Znf_U1 | 5.56e-03 | 29 | 72 | 2 | IPR003604 | |
| Domain | SNF2_N | 6.75e-03 | 32 | 72 | 2 | IPR000330 | |
| Domain | SNF2_N | 6.75e-03 | 32 | 72 | 2 | PF00176 | |
| Domain | - | 7.66e-03 | 449 | 72 | 6 | 3.30.40.10 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.41e-04 | 301 | 54 | 7 | MM15983 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.43e-04 | 5 | 54 | 2 | M45554 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.14e-04 | 6 | 54 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.14e-04 | 6 | 54 | 2 | M22047 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 2.99e-04 | 7 | 54 | 2 | MM1541 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 3.97e-04 | 8 | 54 | 2 | M22015 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 5.49e-04 | 42 | 54 | 3 | M27172 | |
| Pathway | PID_HNF3A_PATHWAY | 6.30e-04 | 44 | 54 | 3 | M285 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 6.73e-04 | 45 | 54 | 3 | MM15877 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 7.65e-04 | 47 | 54 | 3 | M48301 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 7.75e-04 | 11 | 54 | 2 | M48021 | |
| Pubmed | TET2 BPTF SP1 KMT2D ZFHX4 EP400 DCP1B FOXP2 SCAF8 DDX18 YLPM1 CCAR1 TNRC6B GIGYF2 SMARCD1 POU2F1 FOXP1 GIGYF1 MLLT10 RFXAP CREBBP EMSY PHF21A PRRC2B | 7.59e-16 | 1429 | 73 | 24 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 BPTF KMT2D ARGFX ZFHX4 EP400 FOXP2 SMARCD1 POU2F1 FOXP1 CREBBP EMSY PHF21A PRRC2B | 1.90e-14 | 351 | 73 | 14 | 38297188 |
| Pubmed | BPTF ZFHX4 EP400 FOXP2 PHLDA1 DDX18 CIZ1 TNRC6B SMARCD1 CHD9 FOXP1 CEP295 GIGYF1 CREBBP PHF21A PRRC2B PROX1 | 1.17e-10 | 1116 | 73 | 17 | 31753913 | |
| Pubmed | TET2 KMT2D EP400 YLPM1 SMARCD1 FOXP1 CREBBP EMSY PHF21A PRRC2B | 2.53e-10 | 268 | 73 | 10 | 33640491 | |
| Pubmed | TET2 BPTF SP4 KMT2D EP400 BAZ2B SF3A1 CCAR1 SMARCD1 POU2F1 CHD9 FOXP1 CREBBP EMSY PHF21A PRRC2B | 9.09e-10 | 1103 | 73 | 16 | 34189442 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23540600 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 8.87e-09 | 3 | 73 | 3 | 18593936 | |
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 8.87e-09 | 3 | 73 | 3 | 11532028 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21919647 | ||
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 8.87e-09 | 3 | 73 | 3 | 7559627 | |
| Pubmed | BPTF SP1 SP3 SP4 FOXP2 CIZ1 CCAR1 SMARCD1 POU2F1 FOXP1 MLLT10 ZMYM5 PHF21A | 1.25e-08 | 808 | 73 | 13 | 20412781 | |
| Pubmed | TET2 KMT2D MRTFB ZFHX4 TNRC6B GIGYF2 FOXP1 ZMYM5 PHF21A PROX1 | 1.79e-08 | 418 | 73 | 10 | 34709266 | |
| Pubmed | BPTF KMT2D MRTFB EP400 YLPM1 CIZ1 TNRC6B GIGYF2 CREBBP EMSY PRRC2B | 2.02e-08 | 549 | 73 | 11 | 38280479 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 15781457 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 15511642 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 27889927 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BPTF SP1 KMT2D EP400 SCAF8 SF3A1 MINK1 YLPM1 CCAR1 GIGYF2 POU2F1 EMSY | 7.20e-08 | 774 | 73 | 12 | 15302935 |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 10362258 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 20538607 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 10547281 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 12560508 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 16061936 | ||
| Pubmed | 1.53e-07 | 23 | 73 | 4 | 9225980 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.57e-07 | 398 | 73 | 9 | 35016035 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 18348986 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 16201967 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 16734381 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KPNA5 BPTF KMT2D ZFHX4 EP400 FOXP2 SF3A1 POU2F1 FOXP1 CREBBP EMSY PHF21A | 2.15e-07 | 857 | 73 | 12 | 25609649 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.00e-07 | 430 | 73 | 9 | 35044719 | |
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 12004059 | ||
| Pubmed | 3.52e-07 | 28 | 73 | 4 | 29365100 | ||
| Pubmed | 4.48e-07 | 222 | 73 | 7 | 37071664 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.98e-07 | 457 | 73 | 9 | 32344865 | |
| Pubmed | 1.02e-06 | 157 | 73 | 6 | 30186101 | ||
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 1.05e-06 | 10 | 73 | 3 | 15619633 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BPTF SP1 KMT2D EP400 BAZ2B SF3A1 DDX18 YLPM1 CIZ1 CCAR1 RFXAP EMSY PHF21A | 2.67e-06 | 1294 | 73 | 13 | 30804502 |
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 3.18e-06 | 14 | 73 | 3 | 10976766 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 3.86e-06 | 307 | 73 | 7 | 37499664 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 8668525 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 4.35e-06 | 2 | 73 | 2 | 31299490 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30031127 | ||
| Pubmed | O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. | 4.35e-06 | 2 | 73 | 2 | 19070619 | |
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 4.35e-06 | 2 | 73 | 2 | 30104377 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25175639 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 14766015 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25538045 | ||
| Pubmed | Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions. | 4.35e-06 | 2 | 73 | 2 | 19124469 | |
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 4.35e-06 | 2 | 73 | 2 | 31164147 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 4.35e-06 | 2 | 73 | 2 | 37735515 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26807725 | ||
| Pubmed | An Sp1/Sp3 binding polymorphism confers methylation protection. | 4.35e-06 | 2 | 73 | 2 | 18725933 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15951564 | ||
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 4.35e-06 | 2 | 73 | 2 | 22464952 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19437621 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 4.35e-06 | 2 | 73 | 2 | 8845379 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24893771 | ||
| Pubmed | Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3. | 4.35e-06 | 2 | 73 | 2 | 21604172 | |
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 4.35e-06 | 2 | 73 | 2 | 15056695 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 1454515 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21248046 | ||
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 4.35e-06 | 2 | 73 | 2 | 15816870 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25853299 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 27224915 | ||
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 4.35e-06 | 2 | 73 | 2 | 9628590 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11358962 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28741757 | ||
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 4.35e-06 | 2 | 73 | 2 | 14608051 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 4.35e-06 | 2 | 73 | 2 | 27999180 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23941741 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 4.35e-06 | 2 | 73 | 2 | 38761373 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31311407 | ||
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 4.35e-06 | 2 | 73 | 2 | 9329821 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26647308 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 4.86e-06 | 318 | 73 | 7 | 16919269 | |
| Pubmed | 6.48e-06 | 57 | 73 | 4 | 24952745 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.66e-06 | 341 | 73 | 7 | 32971831 | |
| Pubmed | 9.86e-06 | 20 | 73 | 3 | 33431871 | ||
| Pubmed | 1.02e-05 | 234 | 73 | 6 | 36243803 | ||
| Pubmed | 1.10e-05 | 65 | 73 | 4 | 22496869 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15821099 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17652716 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 9525610 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12730302 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18417714 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12694199 | ||
| Pubmed | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | 1.30e-05 | 3 | 73 | 2 | 14701757 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15118068 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34463256 | ||
| Pubmed | Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors. | 1.30e-05 | 3 | 73 | 2 | 17317039 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11850421 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18314536 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14516685 | ||
| Pubmed | Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. | 1.30e-05 | 3 | 73 | 2 | 11274368 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 36759621 | ||
| Pubmed | Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells. | 1.30e-05 | 3 | 73 | 2 | 16529657 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11237613 | ||
| Pubmed | Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. | 1.30e-05 | 3 | 73 | 2 | 23028678 | |
| Interaction | CRX interactions | TET2 SP1 SP3 SP4 KMT2D ZFHX4 EP400 FOXP2 POU2F1 FOXP1 OSTF1 CREBBP PRRC2B | 5.46e-12 | 254 | 72 | 13 | int:CRX |
| Interaction | FEV interactions | KMT2D ZFHX4 EP400 FOXP2 POU2F1 FOXP1 MLLT10 CREBBP EMSY PHF21A PRRC2B | 1.46e-10 | 203 | 72 | 11 | int:FEV |
| Interaction | EGR2 interactions | TET2 KMT2D ZFHX4 EP400 FOXP2 FOXP1 CREBBP EMSY PHF21A PRRC2B | 5.06e-10 | 171 | 72 | 10 | int:EGR2 |
| Interaction | SP7 interactions | TET2 KMT2D ZFHX4 EP400 SCAF8 YLPM1 CCAR1 SMARCD1 POU2F1 FOXP1 CREBBP PRRC2B | 7.66e-10 | 304 | 72 | 12 | int:SP7 |
| Interaction | HNF1B interactions | TET2 BPTF KMT2D ZFHX4 EP400 SMARCD1 FOXP1 MLLT10 CREBBP PRRC2B | 1.41e-09 | 190 | 72 | 10 | int:HNF1B |
| Interaction | KLF5 interactions | TET2 ATXN3L KMT2D EP400 DDX18 SMARCD1 FOXP1 MLLT10 CREBBP PRRC2B | 1.82e-09 | 195 | 72 | 10 | int:KLF5 |
| Interaction | PAX6 interactions | BPTF KMT2D ZFHX4 EP400 SMARCD1 POU2F1 FOXP1 RFXAP CREBBP PHF21A PRRC2B PROX1 | 6.21e-09 | 366 | 72 | 12 | int:PAX6 |
| Interaction | FHL2 interactions | SP1 SP3 SP4 MAGEL2 MRTFB EP400 ODAM CCAR1 FOXP1 CREBBP EMSY PHF21A | 1.49e-08 | 396 | 72 | 12 | int:FHL2 |
| Interaction | HNF4A interactions | 4.84e-08 | 275 | 72 | 10 | int:HNF4A | |
| Interaction | ERG interactions | 9.84e-08 | 223 | 72 | 9 | int:ERG | |
| Interaction | NFIX interactions | 1.15e-07 | 227 | 72 | 9 | int:NFIX | |
| Interaction | PAX8 interactions | 1.39e-07 | 111 | 72 | 7 | int:PAX8 | |
| Interaction | GCM1 interactions | 1.55e-07 | 68 | 72 | 6 | int:GCM1 | |
| Interaction | ETS1 interactions | 2.52e-07 | 121 | 72 | 7 | int:ETS1 | |
| Interaction | KLF8 interactions | 2.57e-07 | 329 | 72 | 10 | int:KLF8 | |
| Interaction | SOX7 interactions | 4.75e-07 | 82 | 72 | 6 | int:SOX7 | |
| Interaction | SP4 interactions | 6.18e-07 | 46 | 72 | 5 | int:SP4 | |
| Interaction | GSC interactions | 6.76e-07 | 87 | 72 | 6 | int:GSC | |
| Interaction | FOXI1 interactions | 9.41e-07 | 92 | 72 | 6 | int:FOXI1 | |
| Interaction | CEBPA interactions | TET2 BPTF SP4 KMT2D EP400 BAZ2B SF3A1 DDX18 CCAR1 SMARCD1 POU2F1 CHD9 FOXP1 CREBBP EMSY PHF21A PRRC2B | 1.32e-06 | 1245 | 72 | 17 | int:CEBPA |
| Interaction | HDAC1 interactions | TET2 BPTF SP1 SP3 KMT2D MRTFB ZFHX4 EP400 SF3A1 TNRC6B GIGYF2 SMARCD1 POU2F1 CREBBP EMSY PHF21A | 1.40e-06 | 1108 | 72 | 16 | int:HDAC1 |
| Interaction | NUP43 interactions | BPTF KMT2D MRTFB ARGFX EP400 BAZ2B DDX18 CIZ1 TNRC6B CHD9 EMSY PHF21A | 2.00e-06 | 625 | 72 | 12 | int:NUP43 |
| Interaction | TBXT interactions | 3.66e-06 | 116 | 72 | 6 | int:TBXT | |
| Interaction | ELK3 interactions | 4.46e-06 | 120 | 72 | 6 | int:ELK3 | |
| Interaction | GATA3 interactions | 4.69e-06 | 187 | 72 | 7 | int:GATA3 | |
| Interaction | FOXP2 interactions | 5.11e-06 | 70 | 72 | 5 | int:FOXP2 | |
| Interaction | PAX7 interactions | 5.39e-06 | 124 | 72 | 6 | int:PAX7 | |
| Interaction | NUP62CL interactions | 9.05e-06 | 37 | 72 | 4 | int:NUP62CL | |
| Interaction | AR interactions | TET2 SP1 KMT2D EP400 YLPM1 MED12L CCAR1 SMARCD1 POU2F1 FOXP1 CREBBP EMSY PHF21A PRRC2B | 9.24e-06 | 992 | 72 | 14 | int:AR |
| Interaction | SP3 interactions | 1.25e-05 | 84 | 72 | 5 | int:SP3 | |
| Interaction | IRF4 interactions | 1.33e-05 | 85 | 72 | 5 | int:IRF4 | |
| Interaction | SMG7 interactions | 1.79e-05 | 319 | 72 | 8 | int:SMG7 | |
| Interaction | NUP35 interactions | 1.96e-05 | 424 | 72 | 9 | int:NUP35 | |
| Interaction | TEAD1 interactions | 3.95e-05 | 176 | 72 | 6 | int:TEAD1 | |
| Interaction | NFYC interactions | 4.08e-05 | 177 | 72 | 6 | int:NFYC | |
| Interaction | TBR1 interactions | 5.26e-05 | 113 | 72 | 5 | int:TBR1 | |
| Interaction | NR2F1 interactions | 5.49e-05 | 58 | 72 | 4 | int:NR2F1 | |
| Interaction | ELF4 interactions | 5.72e-05 | 115 | 72 | 5 | int:ELF4 | |
| Interaction | TLE3 interactions | 5.76e-05 | 376 | 72 | 8 | int:TLE3 | |
| Interaction | TNRC6A interactions | 6.32e-05 | 280 | 72 | 7 | int:TNRC6A | |
| Interaction | MYOD1 interactions | 6.79e-05 | 194 | 72 | 6 | int:MYOD1 | |
| Interaction | H2AC4 interactions | 7.72e-05 | 506 | 72 | 9 | int:H2AC4 | |
| Interaction | GATA2 interactions | 7.81e-05 | 199 | 72 | 6 | int:GATA2 | |
| Interaction | TLX3 interactions | 8.04e-05 | 291 | 72 | 7 | int:TLX3 | |
| Interaction | NFIC interactions | 1.05e-04 | 210 | 72 | 6 | int:NFIC | |
| Interaction | PPARG interactions | 1.12e-04 | 307 | 72 | 7 | int:PPARG | |
| Interaction | ZFHX4 interactions | 1.35e-04 | 73 | 72 | 4 | int:ZFHX4 | |
| Interaction | KLF3 interactions | 1.65e-04 | 228 | 72 | 6 | int:KLF3 | |
| Interaction | CPEB1 interactions | 1.76e-04 | 146 | 72 | 5 | int:CPEB1 | |
| Interaction | CNOT9 interactions | 1.77e-04 | 231 | 72 | 6 | int:CNOT9 | |
| Interaction | INSC interactions | 1.83e-04 | 31 | 72 | 3 | int:INSC | |
| Interaction | SLX4 interactions | 1.95e-04 | 572 | 72 | 9 | int:SLX4 | |
| Interaction | USP7 interactions | TET2 DNHD1 SP1 SP3 SP4 KMT2D MAGEL2 MINK1 YLPM1 CCAR1 GIGYF2 DNAH5 CREBBP AGBL3 | 1.96e-04 | 1313 | 72 | 14 | int:USP7 |
| Interaction | YY1 interactions | 2.11e-04 | 454 | 72 | 8 | int:YY1 | |
| Interaction | PHF21A interactions | 2.22e-04 | 343 | 72 | 7 | int:PHF21A | |
| Interaction | PGR interactions | 2.33e-04 | 84 | 72 | 4 | int:PGR | |
| Interaction | PAX2 interactions | 2.44e-04 | 85 | 72 | 4 | int:PAX2 | |
| Interaction | KPNA1 interactions | 2.55e-04 | 351 | 72 | 7 | int:KPNA1 | |
| Interaction | TNFSF10 interactions | 2.64e-04 | 35 | 72 | 3 | int:TNFSF10 | |
| Interaction | SOX5 interactions | 2.86e-04 | 162 | 72 | 5 | int:SOX5 | |
| Interaction | MSX1 interactions | 2.87e-04 | 36 | 72 | 3 | int:MSX1 | |
| Interaction | DYRK1B interactions | 3.17e-04 | 91 | 72 | 4 | int:DYRK1B | |
| Interaction | PHOX2A interactions | 3.48e-04 | 8 | 72 | 2 | int:PHOX2A | |
| Interaction | RORA interactions | 3.64e-04 | 39 | 72 | 3 | int:RORA | |
| Interaction | GATA1 interactions | 3.67e-04 | 171 | 72 | 5 | int:GATA1 | |
| Interaction | SOX9 interactions | 4.04e-04 | 97 | 72 | 4 | int:SOX9 | |
| Interaction | TLX1 interactions | 4.08e-04 | 175 | 72 | 5 | int:TLX1 | |
| Interaction | FOXP4 interactions | 4.20e-04 | 98 | 72 | 4 | int:FOXP4 | |
| Interaction | SNRNP40 interactions | 4.29e-04 | 637 | 72 | 9 | int:SNRNP40 | |
| Interaction | GIGYF1 interactions | 4.29e-04 | 177 | 72 | 5 | int:GIGYF1 | |
| Interaction | PATL1 interactions | 4.29e-04 | 177 | 72 | 5 | int:PATL1 | |
| Interaction | TFCP2L1 interactions | 4.36e-04 | 99 | 72 | 4 | int:TFCP2L1 | |
| Interaction | ARGFX interactions | 4.46e-04 | 9 | 72 | 2 | int:ARGFX | |
| Interaction | ZFP36 interactions | 4.76e-04 | 181 | 72 | 5 | int:ZFP36 | |
| Interaction | KDM1A interactions | TET2 KMT2D MRTFB ZFHX4 EP400 TNRC6B GIGYF2 SMARCD1 FOXP1 PHF21A PROX1 | 4.82e-04 | 941 | 72 | 11 | int:KDM1A |
| Interaction | ALG13 interactions | 5.00e-04 | 183 | 72 | 5 | int:ALG13 | |
| Interaction | LHX2 interactions | 5.00e-04 | 183 | 72 | 5 | int:LHX2 | |
| Interaction | TNRC6B interactions | 5.13e-04 | 282 | 72 | 6 | int:TNRC6B | |
| Interaction | LHX3 interactions | 5.25e-04 | 185 | 72 | 5 | int:LHX3 | |
| Interaction | RNF214 interactions | 5.26e-04 | 104 | 72 | 4 | int:RNF214 | |
| Interaction | NFYA interactions | 5.45e-04 | 105 | 72 | 4 | int:NFYA | |
| Interaction | RBBP5 interactions | 5.63e-04 | 287 | 72 | 6 | int:RBBP5 | |
| Interaction | CELF1 interactions | 5.73e-04 | 288 | 72 | 6 | int:CELF1 | |
| Interaction | PHF12 interactions | 6.50e-04 | 110 | 72 | 4 | int:PHF12 | |
| Interaction | S100A2 interactions | 6.66e-04 | 412 | 72 | 7 | int:S100A2 | |
| Interaction | PHIP interactions | 6.98e-04 | 197 | 72 | 5 | int:PHIP | |
| Interaction | EIF4ENIF1 interactions | 7.09e-04 | 300 | 72 | 6 | int:EIF4ENIF1 | |
| Interaction | E2F1 interactions | 7.47e-04 | 200 | 72 | 5 | int:E2F1 | |
| Interaction | WWTR1 interactions | 7.67e-04 | 422 | 72 | 7 | int:WWTR1 | |
| Interaction | KLF16 interactions | 7.99e-04 | 425 | 72 | 7 | int:KLF16 | |
| Interaction | TRIM66 interactions | 8.35e-04 | 205 | 72 | 5 | int:TRIM66 | |
| Interaction | TIAM1 interactions | 8.35e-04 | 205 | 72 | 5 | int:TIAM1 | |
| Interaction | NKX3-1 interactions | 8.52e-04 | 52 | 72 | 3 | int:NKX3-1 | |
| Interaction | YTHDF2 interactions | 8.70e-04 | 312 | 72 | 6 | int:YTHDF2 | |
| Interaction | MNAT1 interactions | 8.72e-04 | 119 | 72 | 4 | int:MNAT1 | |
| Interaction | HLF interactions | 9.57e-04 | 13 | 72 | 2 | int:HLF | |
| Interaction | BNC2 interactions | 9.57e-04 | 13 | 72 | 2 | int:BNC2 | |
| Interaction | LATS1 interactions | 9.79e-04 | 440 | 72 | 7 | int:LATS1 | |
| Interaction | MEN1 interactions | BPTF KMT2D MRTFB EP400 SF3A1 DDX18 YLPM1 GIGYF2 SMARCD1 FOXP1 EMSY | 1.01e-03 | 1029 | 72 | 11 | int:MEN1 |
| Interaction | TPRX2 interactions | 1.06e-03 | 56 | 72 | 3 | int:TPRX2 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.05e-09 | 25 | 49 | 5 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.55e-06 | 9 | 49 | 3 | 755 | |
| GeneFamily | PHD finger proteins | 4.38e-06 | 90 | 49 | 5 | 88 | |
| GeneFamily | Forkhead boxes | 6.05e-03 | 43 | 49 | 2 | 508 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.13e-07 | 180 | 73 | 7 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 7.83e-06 | 169 | 73 | 6 | M39230 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 1.98e-05 | 199 | 73 | 6 | M3151 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.04e-05 | 200 | 73 | 6 | M9449 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.41e-05 | 206 | 73 | 6 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.54e-05 | 208 | 73 | 6 | MM581 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 4.60e-05 | 466 | 73 | 8 | M13522 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BPTF SP3 KMT2D EP400 GVINP1 PHLDA1 SCAF8 SF3A1 TNRC6B OSTF1 CREBBP GLCCI1 ZMYM5 PRRC2B | 5.51e-05 | 1492 | 73 | 14 | M40023 |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN | 1.29e-04 | 279 | 73 | 6 | M250 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.63e-04 | 38 | 73 | 3 | M39244 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.87e-04 | 189 | 73 | 5 | M3112 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 2.11e-04 | 194 | 73 | 5 | M3321 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 2.32e-04 | 198 | 73 | 5 | M7948 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP | 2.37e-04 | 199 | 73 | 5 | M7845 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 2.43e-04 | 200 | 73 | 5 | M5063 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 2.43e-04 | 200 | 73 | 5 | M9354 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.43e-04 | 200 | 73 | 5 | M8997 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 2.43e-04 | 200 | 73 | 5 | M9765 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 2.43e-04 | 200 | 73 | 5 | M9203 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 2.43e-04 | 200 | 73 | 5 | M3165 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 160 | 73 | 5 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 1.37e-05 | 186 | 73 | 5 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.37e-05 | 186 | 73 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-05 | 190 | 73 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 191 | 73 | 5 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 191 | 73 | 5 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 191 | 73 | 5 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 191 | 73 | 5 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 197 | 73 | 5 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.89e-05 | 199 | 73 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.17e-05 | 44 | 73 | 3 | 405ac4aeee539322cfe661c7531248f81271be8d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.17e-05 | 44 | 73 | 3 | a2c99e8ca635590a1f167b68bc390e2aa01e26be | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 128 | 73 | 4 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-05 | 130 | 73 | 4 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 138 | 73 | 4 | 2e46d546ad962aa0fde5b1c18c2a5370a4424e9f | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.20e-04 | 154 | 73 | 4 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 73 | 4 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 73 | 4 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.32e-04 | 158 | 73 | 4 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.32e-04 | 158 | 73 | 4 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.32e-04 | 158 | 73 | 4 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-04 | 159 | 73 | 4 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.35e-04 | 159 | 73 | 4 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.49e-04 | 163 | 73 | 4 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 166 | 73 | 4 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 166 | 73 | 4 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-04 | 167 | 73 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 167 | 73 | 4 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 167 | 73 | 4 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 172 | 73 | 4 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.87e-04 | 173 | 73 | 4 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.87e-04 | 173 | 73 | 4 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 175 | 73 | 4 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-04 | 176 | 73 | 4 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 178 | 73 | 4 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 178 | 73 | 4 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 178 | 73 | 4 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 178 | 73 | 4 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 180 | 73 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-04 | 181 | 73 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 182 | 73 | 4 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 183 | 73 | 4 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 184 | 73 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.41e-04 | 185 | 73 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 185 | 73 | 4 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-04 | 186 | 73 | 4 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-04 | 188 | 73 | 4 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-04 | 188 | 73 | 4 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-04 | 188 | 73 | 4 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.57e-04 | 188 | 73 | 4 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 192 | 73 | 4 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.78e-04 | 192 | 73 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 192 | 73 | 4 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 192 | 73 | 4 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-04 | 193 | 73 | 4 | 2b80991e7ba7640f7ab2139d30e4c54d8e533862 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-04 | 193 | 73 | 4 | 90cfc34c2d0d7c70f071703d35db1d6037961481 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 2.83e-04 | 193 | 73 | 4 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 2.83e-04 | 193 | 73 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.89e-04 | 194 | 73 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.89e-04 | 194 | 73 | 4 | a7bfc535546d3c1a4e0cbcfeb7da816b34303350 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 195 | 73 | 4 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-04 | 195 | 73 | 4 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 195 | 73 | 4 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-04 | 195 | 73 | 4 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 196 | 73 | 4 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.01e-04 | 196 | 73 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.01e-04 | 196 | 73 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-04 | 197 | 73 | 4 | 479841809554a9d0b1e4f23da6e657392b0f4971 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 197 | 73 | 4 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 197 | 73 | 4 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.06e-04 | 197 | 73 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 197 | 73 | 4 | fc718a254bda4df2d62975d04393492fb75ab305 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.12e-04 | 198 | 73 | 4 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 73 | 4 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 73 | 4 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.12e-04 | 198 | 73 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 73 | 4 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.12e-04 | 198 | 73 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-04 | 199 | 73 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-04 | 199 | 73 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.18e-04 | 199 | 73 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-04 | 199 | 73 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 7.62e-08 | 171 | 73 | 8 | 7535_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; HL60; HT_HG-U133A | 3.39e-06 | 198 | 73 | 7 | 2397_UP | |
| Drug | SP 0 | 3.73e-06 | 10 | 73 | 3 | CID002742752 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.17e-05 | 176 | 73 | 6 | 1212_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.62e-05 | 182 | 73 | 6 | 3887_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.71e-05 | 183 | 73 | 6 | 7498_DN | |
| Drug | homocysteic acid | 3.04e-05 | 3 | 73 | 2 | ctd:C007956 | |
| Drug | stanolone benzoate | 3.04e-05 | 3 | 73 | 2 | ctd:C040109 | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3063_UP | |
| Drug | Succimer | TET2 PDE1A ZFHX4 PHLDA1 BAZ2B STARD9 TNRC6B GIGYF2 CHD9 FOXP1 MLLT10 LCN2 RIMS2 CREBBP | 4.18e-05 | 1264 | 73 | 14 | ctd:D004113 |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 5507_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 6509_UP | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 4002_UP | |
| Drug | hyperoside | 6.10e-05 | 24 | 73 | 3 | ctd:C021304 | |
| Drug | Magnetite Nanoparticles | TET2 PDE1A ZFHX4 PHLDA1 BAZ2B STARD9 TNRC6B GIGYF2 CHD9 FOXP1 MLLT10 LCN2 RIMS2 CREBBP | 6.15e-05 | 1310 | 73 | 14 | ctd:D058185 |
| Drug | ADP-ribosylarginine | 6.91e-05 | 25 | 73 | 3 | CID000126311 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.49e-05 | 68 | 73 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | specific developmental disorder (implicated_via_orthology) | 3.61e-05 | 4 | 73 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 4.07e-05 | 27 | 73 | 3 | C0036920 | |
| Disease | neuroticism measurement, cognitive function measurement | 7.85e-05 | 566 | 73 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | mean fractional anisotropy measurement | 9.26e-05 | 95 | 73 | 4 | EFO_0008399 | |
| Disease | breast cancer, ovarian carcinoma | 1.06e-04 | 37 | 73 | 3 | EFO_0001075, MONDO_0007254 | |
| Disease | neutrophil percentage of leukocytes | 1.32e-04 | 610 | 73 | 8 | EFO_0007990 | |
| Disease | apolipoprotein B measurement | 2.32e-04 | 663 | 73 | 8 | EFO_0004615 | |
| Disease | red blood cell density measurement | 3.15e-04 | 880 | 73 | 9 | EFO_0007978 | |
| Disease | Lymphoma, Large-Cell, Follicular | 6.21e-04 | 15 | 73 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 6.21e-04 | 15 | 73 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 6.21e-04 | 15 | 73 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 6.21e-04 | 15 | 73 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 6.21e-04 | 15 | 73 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 6.21e-04 | 15 | 73 | 2 | C1956130 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 6.21e-04 | 15 | 73 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | insomnia measurement | 8.07e-04 | 443 | 73 | 6 | EFO_0007876 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 8.08e-04 | 801 | 73 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 9.00e-04 | 18 | 73 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Lymphoma, Follicular | 1.11e-03 | 20 | 73 | 2 | C0024301 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.20e-03 | 84 | 73 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | reaction time measurement | 1.21e-03 | 658 | 73 | 7 | EFO_0008393 | |
| Disease | Neurodevelopmental Disorders | 1.61e-03 | 93 | 73 | 3 | C1535926 | |
| Disease | congenital heart disease (is_implicated_in) | 1.61e-03 | 24 | 73 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | childhood trauma measurement | 1.61e-03 | 24 | 73 | 2 | EFO_0007979 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.69e-03 | 346 | 73 | 5 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | cortical surface area measurement | 1.70e-03 | 1345 | 73 | 10 | EFO_0010736 | |
| Disease | multisite chronic pain | 1.71e-03 | 95 | 73 | 3 | EFO_0010100 | |
| Disease | ergothioneine measurement | 1.89e-03 | 26 | 73 | 2 | EFO_0021163 | |
| Disease | gastroesophageal reflux disease | 2.03e-03 | 101 | 73 | 3 | EFO_0003948 | |
| Disease | smoking status measurement | 2.21e-03 | 1160 | 73 | 9 | EFO_0006527 | |
| Disease | gas trapping measurement | 2.35e-03 | 29 | 73 | 2 | EFO_0007628 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQAVQQQKAIQPQAA | 2971 | Q96L91 | |
| QIKQLFNPRTNFQIQ | 846 | Q8NEM8 | |
| QPQQALYSVQQQLQQ | 86 | Q8IX12 | |
| QSQQKQPQVLSQQLP | 341 | Q9UIF8 | |
| KQQQPLALTQQEQQQ | 931 | P41180 | |
| QNQLINQIQNGKIQT | 1766 | Q7Z2Y8 | |
| QQQQQSAKQRNQILP | 136 | A6NJG6 | |
| QQQQQVLNILKSNPQ | 2081 | Q92793 | |
| QQPSQQQQLLQELQG | 521 | Q86VQ1 | |
| NPKIQQALNIQQVLL | 686 | Q96M86 | |
| QQIKLQLPIQIQQSS | 2591 | Q12830 | |
| PEINAVQLQNLLNQM | 531 | A8MX76 | |
| PQVDENQQQFIFQQQ | 516 | O15131 | |
| QLTQQLQSVIPNNNV | 1476 | O60309 | |
| IQVQNLLQLFNIPQI | 156 | P41594 | |
| LFPRQGLQQTQQQQQ | 2101 | Q86YW9 | |
| QKAVQIQLPPQQAQA | 656 | Q9UJ55 | |
| PPQQQQQQLTAFLQQ | 601 | O75420 | |
| QQQLTAFLQQLQALK | 606 | O75420 | |
| QPTQQIKNIVRQYQQ | 2571 | Q9UKN7 | |
| QQEQKQQQQQSDLPG | 291 | Q9H3M9 | |
| FQQIKNIRNSLQQPE | 336 | P54750 | |
| QILQQQVLSPQQLQA | 106 | O15409 | |
| QVLSPQQLQALLQQQ | 111 | O15409 | |
| LSPQQLQVLLQQQQA | 121 | Q9H334 | |
| QQQLFLQLQILSQQK | 321 | Q9ULH7 | |
| LQQQQQAQIPGLSQF | 61 | A1E959 | |
| ENKLQTAQQQPLQQL | 81 | Q96BD5 | |
| KQIFNVNNLNLPQVA | 596 | Q9NVP1 | |
| PAQQQLLLQQAQAQA | 116 | P14859 | |
| LVNNVLQPQQKQQNE | 71 | Q9UQ26 | |
| VPLQQNFQDNQFQGK | 36 | P80188 | |
| IVQANKLLQNQEPVN | 131 | Q5TID7 | |
| QQQQQQEKLPIRQGV | 256 | Q8IZD4 | |
| NKNRQIQQIQPTFSV | 1796 | Q3L8U1 | |
| LIQQQYAQVLAQQQK | 631 | Q6Y7W6 | |
| AKQKANQQRQQQQLP | 1196 | Q6Y7W6 | |
| RATVPFQLKQQQQQQ | 36 | Q6P1L5 | |
| QQQQQQQANVIFKPI | 496 | Q13495 | |
| QAQLNQTKEQLPDQQ | 551 | Q96JA4 | |
| QSPKQQLYQVQQQTQ | 406 | Q7Z589 | |
| QNNQINNAGIPQDLK | 61 | Q9NZU1 | |
| QPILSQQNNFKFLQE | 941 | Q9C0D2 | |
| QQNNFKFLQEQLNIQ | 946 | Q9C0D2 | |
| SQLIQPQQDNLKALQ | 1341 | Q9C0D2 | |
| PQQARQKLQNLFINF | 21 | P26678 | |
| QSPQGQQLQQLIQTL | 196 | Q9UPN6 | |
| NFLQNLQQFPKDTIN | 3361 | Q8TE73 | |
| FTQPNIELNQQNKLG | 126 | Q92882 | |
| QQLQKQQQQQLLPGD | 486 | Q8N4C8 | |
| LSNPDFNIQQLQKQE | 176 | Q86SS6 | |
| IQQQPLQNVQLQAVN | 436 | Q02446 | |
| QILDLNNNQIQTVPK | 446 | Q9BXR5 | |
| KRPAPQQIQQVQQQA | 101 | Q96GM5 | |
| PELRQQLQQKQQYTN | 46 | O15400 | |
| QKLPQQQQQSFQQLV | 211 | Q92786 | |
| PILQAAKFLQQQQQQ | 91 | B7ZBB8 | |
| AKFLQQQQQQAVALG | 96 | B7ZBB8 | |
| QFLQKQQQLLNQQVL | 246 | O00287 | |
| NNLPVLLQNQNSKIA | 1796 | Q9P2P6 | |
| TLQLQNLQVQNPQAQ | 466 | P08047 | |
| QQTTQQQLPQKVQAQ | 121 | Q15459 | |
| QNQQFQINSNDGKPL | 136 | Q13326 | |
| LPAQLQKQQNFQAEL | 2716 | Q9NRC6 | |
| QQQFQQLLNSQQLTP | 971 | P55197 | |
| LQQKQVQPQLQQEAE | 356 | Q9ULV3 | |
| PRQVQLQLQKQVQTQ | 416 | Q9ULV3 | |
| LQQQAQQYQATQPQL | 1751 | Q86UP3 | |
| QQYQATQPQLQPQKQ | 1756 | Q86UP3 | |
| QQCPPQRAQQQQVKQ | 11 | Q96PI1 | |
| LIPPKQLQHQQQQQQ | 181 | Q8WV24 | |
| LPLQNLQNQQIFSVA | 141 | Q02447 | |
| QKSLPPRFQRQQQQQ | 621 | Q5JSZ5 | |
| QLQQILQQYQQIIQP | 411 | P49750 | |
| LELQQQPQQDGQQQL | 116 | P0CG23 | |
| ALLRKQNFQPTAQQQ | 221 | Q9UJ78 | |
| QFAQQIQQQNPELIE | 271 | Q96EQ0 | |
| DKAALLQEQQQQQQP | 61 | Q9BWQ6 | |
| LLQKQEQQQTQQPQT | 956 | Q6N021 | |
| PQFQLACQLLLQQQQ | 1276 | Q9UPQ9 | |
| GSLPLQQQQQQLWQQ | 2806 | O14686 |